Woodley BioReg成立于2000年，致力于帮助制药、生物制药/生物仿制药、医疗保健和医疗器械公司开发和生产高质量的产品，为全球患者提供有效和安全的产品。Woodley BioReg与世界各地的客户合作，从世界上最大的制药公司到新兴的生物技术公司。我们利用在CMC、法规事务、GMP/QA和临床等各个方面的实践经验来加速药品的开发和批准。
Woodley BioReg利用其完善的cGMP认证流程和具有商业竞争力的监管批准策略，帮助其客户在全球范围内成功注册药物，包括在英国和欧盟。在自己的MHRA GMP许可下，Woodley BioReg使其国际客户能够将其产品出口到英国和欧盟进行分销。

Founded in 2000, Woodley BioReg is dedicated to helping pharmaceutical, biopharmaceutical /biosimilar, healthcare and medical device companies develop and manufacture high quality products that are effective and safe for patients worldwide. Woodley BioReg works with a wide range of clients around the world, from the world's largest pharmaceutical companies to start-up biotechnology organisations.  We use our hands-on experience in all aspects of CMC, Regulatory Affairs, GMP/QA and Clinical to accelerate the development and approval of medicinal products.
Woodley BioReg helps its clients to successfully register drugs worldwide including in the UK and EU using its well-established process for cGMP certification and commercially competitive regulatory approval strategies.  Under its own MHRA GMP licence, Woodley BioReg enables its international clients to export their products to the UK and EU for distribution.